Literature DB >> 16079278

Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.

Mariola Fotin-Mleczek1, Stefan Welte, Oliver Mader, Falk Duchardt, Rainer Fischer, Hansjörg Hufnagel, Peter Scheurich, Roland Brock.   

Abstract

Cationic cell-penetrating peptides (CPPs) have been used widely as delivery vectors for the import of molecules that otherwise do not cross the plasma membrane of eukaryotic cells. In this work, we demonstrate that the three cationic CPPs, Antennapedia homeodomain-derived peptide (Antp), nona-arginine and Tat-derived peptide, inhibit tumour necrosis factor (TNF)-mediated signal transduction. This inhibition is based on the downregulation of TNF receptors at the cell surface by induction of internalization. In contrast to TNF-dependent receptor internalization, no receptor activation occurs. The receptor downregulation is not restricted to the CPPs. Remarkably, the HIV-1 Tat protein itself also induces the internalization of TNF receptors. The dynamin dependence of the internalization, as well as the fact that epidermal growth factor receptors are also internalized, suggest a general induction of clathrin-dependent endocytosis as the mechanism of action. The significance of these findings for the use of cationic CPPs in the import of bioactive peptides is demonstrated here using a conjugate consisting of Antp and a Smac protein-derived cargo peptide. The cargo alone, when introduced into cells by electroporation, enhanced TNF-induced apoptosis by inhibiting the anti-apoptotic action of IAPs (inhibitor of apoptosis proteins). For the Antp-Smac conjugate at concentrations below 40 muM the inhibitory effect of the Antp peptide compensated for the pro-apoptotic activity of the cargo, and led to the protection of cells against TNF-mediated apoptosis. These data provide important new information for the use of cationic CPPs for the cellular delivery of bioactive molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079278     DOI: 10.1242/jcs.02460

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  29 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.

Authors:  Bruno P Meloni; Laura M Brookes; Vince W Clark; Jane L Cross; Adam B Edwards; Ryan S Anderton; Richard M Hopkins; Katrin Hoffmann; Neville W Knuckey
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

Review 3.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

4.  Cell-penetrating peptides with intracellular actin-remodeling activity in malignant fibroblasts.

Authors:  Diane Delaroche; François-Xavier Cantrelle; Frédéric Subra; Carine Van Heijenoort; Eric Guittet; Chen-Yu Jiao; Laurent Blanchoin; Gérard Chassaing; Solange Lavielle; Christian Auclair; Sandrine Sagan
Journal:  J Biol Chem       Date:  2009-12-27       Impact factor: 5.157

5.  Analysis of whole genomic expression profiles and screening of the key signaling pathways associated with pancreatic cancer.

Authors:  Chengzhi He; Hua Jiang; Shasha Geng; Haihui Sheng; Xiaoying Shen; Xiaoyan Zhang; Shizhang Zhu; Ximei Chen; Changqing Yang; Hengjun Gao
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29

Review 6.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

7.  Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.

Authors:  Bruno P Meloni; Diego Milani; Jane L Cross; Vince W Clark; Adam B Edwards; Ryan S Anderton; David J Blacker; Neville W Knuckey
Journal:  Neuromolecular Med       Date:  2017-05-18       Impact factor: 3.843

8.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

9.  The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.

Authors:  Gabriella MacDougall; Ryan S Anderton; Adam B Edwards; Neville W Knuckey; Bruno P Meloni
Journal:  J Mol Neurosci       Date:  2016-11-20       Impact factor: 3.444

10.  Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.

Authors:  Xiaoping Zhang; Yongjiu Jin; Mark R Plummer; Shahriar Pooyan; Simi Gunaseelan; Patrick J Sinko
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.